The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

about

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

Item

http://www.wikidata.org/entity/Q35619274

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@ast

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@en

type

Item

label

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@ast

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@en

prefLabel

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@ast

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@en

P1476

The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.

@en

P2093

Erick Suárez

http://www.w3.org/2001/XMLSchema#string

Lorena González

http://www.w3.org/2001/XMLSchema#string

Marcia Cruz-Correa

http://www.w3.org/2001/XMLSchema#string

Priscilla Magno

http://www.w3.org/2001/XMLSchema#string

P2860

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.

Clinical practice. Barrett's Esophagus.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Increasing incidence of Barrett's oesophagus in the general population.

Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.

Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy.

P304

184-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25563036

http://www.w3.org/2001/XMLSchema#string

P932

4435726

http://www.w3.org/2001/XMLSchema#string